These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 1718375)
41. [Recent trends in cancer treatment using cytokines]. Urushizaki I Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):897-905. PubMed ID: 2471455 [TBL] [Abstract][Full Text] [Related]
42. Overview of advances in the use of biological proteins in human cancer. Gutterman J Semin Oncol; 1988 Oct; 15(5 Suppl 5):2-6. PubMed ID: 2461593 [No Abstract] [Full Text] [Related]
43. Immunological monitoring and clinical trials of biological response modifiers. Urba WJ; Baseler MW Cancer Chemother Biol Response Modif; 1988; 10():473-91. PubMed ID: 2484322 [No Abstract] [Full Text] [Related]
44. [Tumorigenesis, tumor biology and therapeutic measures. New findings]. Gillmann H Arzneimittelforschung; 1987 Feb; 37(2A):236-8. PubMed ID: 2436632 [No Abstract] [Full Text] [Related]
45. Interactions of cytokines in the host. Lundholm K Acta Chir Scand Suppl; 1989; 549():31-4. PubMed ID: 2648715 [No Abstract] [Full Text] [Related]
46. [Progress in the therapy of malignant tumors]. Gropp C Internist (Berl); 1987 Jan; 28(1):44-52. PubMed ID: 2437067 [No Abstract] [Full Text] [Related]
47. The macrophage, TNF, and other cytokines. Pass HI; Mew D; Pass HA; Temeck BK Chest Surg Clin N Am; 1995 Feb; 5(1):73-90. PubMed ID: 7538021 [TBL] [Abstract][Full Text] [Related]
48. Cytokines as anti-cancer agents rational, results and perspectives. Mocellin S Curr Med Chem; 2010; 17(29):3296. PubMed ID: 20712576 [No Abstract] [Full Text] [Related]
49. [Antitumoral action of interferons and interleukins in combination with radiotherapy. Part I: immunologic basis]. Herskind C; Fleckenstein K; Lohr J; Li CY; Wenz F; Lohr F Strahlenther Onkol; 2004 Apr; 180(4):187-93. PubMed ID: 15057428 [TBL] [Abstract][Full Text] [Related]
51. Interleukins, interferons and tumor necrosis factor in cancer treatment. Krigel RL AAOHN J; 1987 Apr; 35(4):159-62. PubMed ID: 2950885 [No Abstract] [Full Text] [Related]
52. Circulating cytokines in patients with metastatic cancer treated with recombinant interleukin 2 and lymphokine-activated killer cells. Gemlo BT; Palladino MA; Jaffe HS; Espevik TP; Rayner AA Cancer Res; 1988 Oct; 48(20):5864-7. PubMed ID: 3139285 [TBL] [Abstract][Full Text] [Related]
53. Immunotherapy of patients with advanced cancer using interleukin-2 alone or in combination with lymphokine activated killer cells. Rosenberg SA Important Adv Oncol; 1988; ():217-57. PubMed ID: 3042605 [No Abstract] [Full Text] [Related]
54. Immunomodulators as local hormones: new insights regarding their clinical utilization. Bocci V J Biol Response Mod; 1985 Aug; 4(4):340-52. PubMed ID: 2411878 [No Abstract] [Full Text] [Related]
58. The 1st Symposium on Local Cytokine Therapy of Cancer: Interleukin-2, Interferon and Related Cytokines. Hamburg, Germany, 29 April-1 May 1999. Abstracts. Anticancer Res; 1999; 19(3A):1995-2016. PubMed ID: 10498578 [No Abstract] [Full Text] [Related]
59. Clinical application of cytokines for cancer treatment. Takaku F Oncology; 1994; 51(2):123-8. PubMed ID: 7515167 [TBL] [Abstract][Full Text] [Related]